Tibor Béres

Dr. Tibor Béres

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 April 2022 in Molecules
Verified
Journal Article
Open access
PDF file
Mária VilkováMária Vilková
Mária Vilková
Monika HudáčováMonika Hudáčová
Monika Hudáčová
NPNikola Palušeková
Nikola Palušeková
Rastislav JendželovskýRastislav Jendželovský
Rastislav Jendželovský
Miroslav AlmasiMiroslav Almasi
Miroslav Almasi
Maria KozurkovaMaria Kozurkova
Maria Kozurkova
A series of novel acridine N-acylhydrazone derivatives have been synthesized as potential topoisomerase I/II inhibitors, and their binding (calf thymus DNA—ctDNA and human serum albumin—HSA) and biological activities as potential anticancer agents on proliferation of A549 and CCD-18Co have been evaluated. The acridine-DNA complex 3b (-F) displayed the highest Kb value (Kb = 3.18 × 103 M−1). The HSA-derivatives interactions were studied by fluorescence quenching spectra. This method was used for the calculation of characteristic binding parameters. In the presence of warfarin, the binding constant values were found to decrease (KSV = 2.26 M−1, Kb = 2.54 M−1), suggesting that derivative 3a could bind to HSA at Sudlow site I. The effect of tested derivatives on metabolic activity of A549 cells evaluated by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide or MTT assay decreased as follows 3b(-F) > 3a(-H) > 3c(-Cl) > 3d(-Br). The derivatives 3c and 3d in vitro act as potential dual inhibitors of hTopo I and II with a partial effect on the metabolic activity of cancer cells A594. The acridine-benzohydrazides 3a and 3c reduced the clonogenic ability of A549 cells by 72% or 74%, respectively. The general results of the study suggest that the novel compounds show potential for future development as anticancer agents.

20 March 2019 in Analytical and Bioanalytical Chemistry
Verified
Journal Article
Closed access
PDF file
TBTibor Béres
Tibor Béres
LČLucie Černochová
Lucie Černochová
SZSanja Ćavar Zeljković
Sanja Ćavar Zeljković
SBSandra Benická
Sandra Benická
TGTomáš Gucký
Tomáš Gucký
Petr TarkowskiPetr Tarkowski
Petr Tarkowski

1 February 2018 in Journal of Molecular Structure
Verified
Journal Article
Closed access
MBMichal Bečka
Michal Bečka
Mária VilkováMária Vilková
Mária Vilková
MŠMichal Šoral
Michal Šoral
IPIvan Potočňák
Ivan Potočňák
MBMartin Breza
Martin Breza
JIJán Imrich
Ján Imrich

7 September 2010 in Analytical and Bioanalytical Chemistry
Verified
Journal Article
Open access
PDF file
TBTibor Béres
Tibor Béres
MZMarek Zatloukal
Marek Zatloukal
JVJiří Voller
Jiří Voller
PNPercy Niemann
Percy Niemann
MGMarie Christin Gahsche
Marie Christin Gahsche
Karel DolezalKarel Dolezal
Karel Dolezal
We describe here a new reversed-phase high-performance liquid chromatography with mass spectrometry detection method for quantifying intact cytokinin nucleotides in human K-562 leukemia cells. Tandem mass spectrometry was used to identify the intracellular metabolites (cytokinin monophosphorylated, diphosphorylated, and triphosphorylated nucleotides) in riboside-treated cells. For the protein precipitation and sample preparation, a trichloroacetic acid extraction method is used. Samples are then back-extracted with diethyl ether, lyophilized, reconstituted, and injected into the LC system. Analytes were quantified in negative selected ion monitoring mode using a single quadrupole mass spectrometer. The method was validated in terms of retention time stabilities, limits of detection, linearity, recovery, and analytical accuracy. The developed method was linear in the range of 1–1,000 pmol for all studied compounds. The limits of detection for the analytes vary from 0.2 to 0.6 pmol.

27 January 2025 in Microorganisms
Verified
Journal Article
Open access
PDF file
MHMartin Helcman
Martin Helcman
Karel ŠmejkalKarel Šmejkal
Karel Šmejkal
MČMarie Čulenová
Marie Čulenová
TBTibor Béres
Tibor Béres
JTJakub Treml
Jakub Treml
Quorum sensing, a bacterial cell-to-cell communication mechanism, plays a key role in bacterial virulence and biofilm formation. Targeting quorum-sensing pathways represents a promising strategy for the development of novel antibacterial agents. This study evaluated the anti-quorum-sensing activities of 18 natural compounds, including cannabinoids, arylbenzofurans, flavonoids, caffeine, and chlorogenic acid, using the luminescent biosensor strain Vibrio harveyi MM30. V. harveyi MM30, a mutant strain deficient in the production of autoinducer-2 (AI-2) but responsive to exogenous AI-2, was used to assess the activity of test compounds on the AI-2 receptor pathway. Test compounds were incubated in AI-2-containing media, and luminescence was measured to evaluate quorum-sensing inhibition. Comparisons were made in the absence of AI-2 to determine AI-2-independent inhibitory activity. The most active compounds were further tested on methicillin-resistant Staphylococcus aureus (MRSA 7112) to determine their effects on AI-2 production in spent media. Among the tested compounds, the non-prenylated arylbenzofuran moracin M and the prenylated arylbenzofuran moracin C exhibited significant quorum-sensing inhibitory activity in the AI-2-mediated pathway. None of the test compounds significantly inhibited quorum sensing in the absence of AI-2. Five compounds (cannabigerol, cannabidiol, cannabigerolic acid, moracin M, and moracin C) were selected for further investigation in MRSA 7112 cultures. The spent media from MRSA 7112 cultures treated with moracin M (16, 32, 64 µg/mL) and cannabigerolic acid (16 µg/mL) showed significant inhibition of AI-2 production when transferred to V. harveyi MM30 cultures. Moracin M and cannabigerolic acid demonstrated potential as quorum-sensing inhibitors by targeting AI-2 production and signalling pathways in MRSA 7112 and V. harveyi. These findings suggest their potential for further development as antibacterial agents targeting quorum-sensing mechanisms.

7 August 2017 in Phytochemical Analysis
Verified
Journal Article
Closed access
PDF file
TBTibor Béres
Tibor Béres
KDKlaus Dragull
Klaus Dragull
Jiri PospisilJiri Pospisil
Jiri Pospisil
Danuse TarkowskaDanuse Tarkowska
Danuse Tarkowska
MDMartin Dančák
Martin Dančák
MSMiroslav Strnad
Miroslav Strnad